These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9822286)

  • 21. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):111. PubMed ID: 25546783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains.
    Dombrowicz D; Flamand V; Miyajima I; Ravetch JV; Galli SJ; Kinet JP
    J Clin Invest; 1997 Mar; 99(5):915-25. PubMed ID: 9062349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivated pepsin inhibits neutrophil activation by Fcgamma-receptor-dependent and independent stimuli.
    Kustiawan I; Derksen N; Rispens T
    Clin Immunol; 2016 Aug; 169():85-88. PubMed ID: 27368805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemically dimerized intravenous immunoglobulin has potent ameliorating activity in a mouse immune thrombocytopenic purpura model.
    Machino Y; Suzuki E; Higurashi S; Ohta H; Suzuki M; Kohroki J; Masuho Y
    Biochem Biophys Res Commun; 2012 Feb; 418(4):748-53. PubMed ID: 22306012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation.
    Olivares N; Marquina B; Mata-Espinoza D; Zatarain-Barron ZL; Pinzón CE; Estrada I; Parada C; Collin M; Rook G; Hernandez-Pando R
    Pathog Dis; 2013 Dec; 69(3):176-83. PubMed ID: 23873753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgM anti-Fc gamma R autoantibodies trigger neutrophil degranulation.
    Boros P; Odin JA; Muryoi T; Masur SK; Bona C; Unkeless JC
    J Exp Med; 1991 Jun; 173(6):1473-82. PubMed ID: 1827827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg).
    Vassilev T; Gelin C; Kaveri SV; Zilber MT; Boumsell L; Kazatchkine MD
    Clin Exp Immunol; 1993 Jun; 92(3):369-72. PubMed ID: 7685668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of immunoglobulin preparations on the opsonic activities against various pathogens].
    Ono Y; Baba M; Ouyatsu I; Nozue N; Ueda Y; Haga T; Guuji A; Nishiya H; Kobayashi K; Kunii O
    Kansenshogaku Zasshi; 1990 Jul; 64(7):854-60. PubMed ID: 2230373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monomerization of dimeric IgG of intravenous immunoglobulin (IVIg) increases the antibody reactivity against intracellular antigens.
    Wymann S; Ghielmetti M; Schaub A; Baumann MJ; Stadler BM; Bolli R; Miescher SM
    Mol Immunol; 2008 May; 45(9):2621-8. PubMed ID: 18280568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta2 integrins are required for neutrophil degranulation induced by hemodialysis membranes.
    Cheung AK; Parker CJ; Hohnholt M
    Kidney Int; 1993 Mar; 43(3):649-60. PubMed ID: 8455364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):87-8. PubMed ID: 25546774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).
    Macias A; Arce S; Leon J; Mustelier G; Bombino G; Domarco A; Perez R; Lage A
    Hybridoma; 1999 Jun; 18(3):263-72. PubMed ID: 10475241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional differences between antiviral activities of sulfonated and intact intravenous immunoglobulin preparations toward varicella-zoster virus and cytomegalovirus.
    Yajima M; Shiraki A; Daikoku T; Oyama Y; Yoshida Y; Shiraki K
    J Infect Chemother; 2015 Jun; 21(6):427-33. PubMed ID: 25824903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional differences between the 40 kDa and 50 to 70 kDa IgG Fc receptors on human neutrophils revealed by elastase treatment and antireceptor antibodies.
    Tosi MF; Berger M
    J Immunol; 1988 Sep; 141(6):2097-103. PubMed ID: 2844894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil chemiluminescence induced by opsonized group A streptococcal particles: an effective probe of intravenous immunoglobulin preparations.
    Rüfenacht R; Chase P; Jungi TW; Morell A
    J Lab Clin Med; 1989 Mar; 113(3):387-95. PubMed ID: 2647877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. sHLA-I contaminating molecules as novel mechanism of ex vivo/in vitro transcriptional and posttranscriptional modulation of transforming growth factor-beta in CD8+ T lymphocytes and neutrophils after intravenous immunoglobulin treatment.
    Ghio M; Contini P; Negrini S; Proietti M; Gonella R; Ubezio G; Ottonello L; Indiveri F
    Transfusion; 2010 Mar; 50(3):547-55. PubMed ID: 19906035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of human intravenous immunoglobulin on canine monocytes and lymphocytes.
    Reagan WJ; Scott-Moncrieff C; Christian J; Snyder P; Kelly K; Glickman L
    Am J Vet Res; 1998 Dec; 59(12):1568-74. PubMed ID: 9858408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation.
    Nachbaur D; Herold M; Eibl B; Glassl H; Schwaighofer H; Huber C; Gächter A; Pichl M; Niederwieser D
    Immunology; 1997 Feb; 90(2):212-8. PubMed ID: 9135549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatidylinositol-linked FcRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst.
    Huizinga TW; Dolman KM; van der Linden NJ; Kleijer M; Nuijens JH; von dem Borne AE; Roos D
    J Immunol; 1990 Feb; 144(4):1432-7. PubMed ID: 2137491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris.
    Mimouni D; Blank M; Ashkenazi L; Milner Y; Frusic-Zlotkin M; Anhalt GJ; David M; Shoenfeld Y
    Clin Exp Immunol; 2005 Dec; 142(3):426-32. PubMed ID: 16297153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.